News moves the market

It’s a crowded market for trade publications covering drug discovery. We know that. We also know that in order to stand out in a crowd you need to be different. With that, we introduce you to Drug Discovery News a trade publication that’s more like the business section of your daily newspaper, than any other publication covering drug discovery. This is no “me too” publication that is feature rich, technology-focused and light on news.
Register for free to listen to this article
Listen with Speechify
0:00
2:00
It's a crowded market for trade publications covering drug discovery. We know that. We also know that in order to stand out in a crowd you need to be different. With that, we introduce you to Drug Discovery News a trade publication that's more like the business section of your daily newspaper, than any other publication covering drug discovery. This is no "me too" publication that is feature rich, technology-focused and light on news.
Continue reading below...
A black mosquito is shown on pink human skin against a blurred green backdrop.
InfographicsDiscovering deeper insights into malaria research
Malaria continues to drive urgent research worldwide, with new therapies and tools emerging to combat the parasite’s complex lifecycle and global burden.
Read More
We are a newspaper. Printed on newsprint. Sized like a newspaper. Designed like a newspaper. Most importantly, we report stories like a newspaper. This means our reporting of the news doesn't begin and end with the company news release. For Drug Discovery News, the press releases that pique our interest are merely the starting point. From there our business news journalists hit the phones and conduct interviews with the principals involved in a story and often those not directly involved to give an outside perspective. In other words, we dig to get the story behind the story and always with a keen eye toward how the story affects the business of drug discovery.
Every issue of Drug Discovery News will have a minimum of five bylined stories in each of the four major sections of the newspaper: informatics, genomics & proteomics, automation & instrumentation and research & development. That's a total of 20 bylined stories each and every month in the major sectors of industry, the sectors that affect how your business operates, how companies come to market, how they compete and where the emerging opportunities lie.
Continue reading below...
A white, pink, and blue 3D molecular structure of a simple sugar is shown against a light purple background.
WebinarsAdding a little sugar: what glycomics can bring to medicine
Discover how glycoscience is transforming how scientists understand diseases and opening new doors for drug discovery.
Read More
But let's be honest, the best concept will not work unless you have the personnel to execute the plan. Well, this premier issue of Drug Discovery News isn't short on editorial experience either. The editors whose work appears in these pages have a combined total of more than 30 years business journalism and trade publishing experience.
To wit:
Chris Anderson has more than 15 years of business journalism and editorial experience. He led the editorial start-up of Security Systems News as its first editor and has also worked on the start-up of two other newspapers, HME News for the home medical equipment industry and the alternative newspaper Casco Bay Weekly in Portland, Maine. Anderson's business journalism spans industries as diverse as semiconductors, custom home electronics and gourmet and specialty foods.
Randall C Willis should be familiar to most of our readers. He is a former editor of the American Chemical Society's Modern Drug Discovery and Journal of Proteome Research. He is also a one-time publisher of his own science magazine. Willis has been writing about and discussing scientific R&D for more than 15 years and brings an in-depth knowledge of drug discovery to these pages.
Continue reading below...
An illustration of various colored microbes, including bacteria and viruses
WebinarsCombatting multidrug-resistant bacterial infections
Organic molecules with novel biological properties offer new ways to eliminate multidrug-resistant bacteria.
Read More
Jeffrey Bouley is a writer and editor with more than 15 years of experience as a freelancer and as managing editor, senior editor and staff editor at a variety of professional and trade magazines.
A graduate of Northwestern University, where he earned bachelor's and master's degrees in journalism, Jeff has spent most of his career covering health, medical and environmental issues.
In short, we have the tools, the knowledge and the wherewithal to provide you with the vital news — business intelligence, if you will —that will make you a more competent player in the market.
So read on and let us know what you think. We think you'll like what you see.

Related Topics

Published In

Loading Next Article...
Loading Next Article...
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

Fluorescent-style illustration of spherical embryonic stem cells clustered together against a dark background.
Explore how emerging in vitro systems — built from primary cells, cocultures, and vascularized tissues — are improving translational research outcomes. 
3D illustration of ciliated cells, with cilia shown in blue.
Ultraprecise proteomic analysis reveals new insights into the molecular machinery of cilia.
3D illustration showing a DNA double helix encapsulated in a transparent capsule, surrounded by abstract white and orange protein-like molecular structures against a blue background.
Discover an integrated analytical approach that unites identification, purification, and stability assessment for therapeutic molecules.
Drug Discovery News December 2025 Issue
Latest IssueVolume 21 • Issue 4 • December 2025

December 2025

December 2025 Issue

Explore this issue